T. Rowe Price Associates
NXGN

T. Rowe Price Associates’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

T. Rowe Price Associates’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-53,217
Closed -$1.26M – 2956
2023
Q3 		$1.26M Buy
53,217
+6,290
+13% +$118K ﹤0.01% 1693
2023
Q2 		$762K Sell
46,927
-6,289
-12% -$104K ﹤0.01% 1938
2023
Q1 		$927K Buy
53,216
+548
+1% +$9.85K ﹤0.01% 1827
2022
Q4 		$989K Buy
52,668
+3,805
+8% +$73.3K ﹤0.01% 1780
2022
Q3 		$865K Buy
48,863
+3,808
+8% +$66.1K ﹤0.01% 1831
2022
Q2 		$786K Sell
45,055
-8,284
-16% -$158K ﹤0.01% 2009
2022
Q1 		$1.11M Sell
53,339
-2,363
-4% -$45.3K ﹤0.01% 1951
2021
Q4 		$991K Buy
55,702
+4,297
+8% +$69K ﹤0.01% 2044
2021
Q3 		$725K Buy
51,405
+5,100
+11% +$79.3K ﹤0.01% 2201
2021
Q2 		$768K Sell
46,305
-10,690
-19% -$192K ﹤0.01% 2180
2021
Q1 		$1.03M Sell
56,995
-13,236
-19% -$261K ﹤0.01% 2030
2020
Q4 		$1.28M Sell
70,231
-2,542
-3% -$40.3K ﹤0.01% 1828
2020
Q3 		$927K Buy
72,773
+7,000
+11% +$89.4K ﹤0.01% 1824
2020
Q2 		$722K Buy
65,773
+4,556
+7% +$47.2K ﹤0.01% 1917
2020
Q1 		$639K Buy
61,217
+365
+0.6% +$4.71K ﹤0.01% 1872
2019
Q4 		$978K Buy
60,852
+2,179
+4% +$36K ﹤0.01% 1894
2019
Q3 		$919K Buy
58,673
+11,518
+24% +$192K ﹤0.01% 1860
2019
Q2 		$938K Buy
47,155
+127
+0.3% +$2.37K ﹤0.01% 1869
2019
Q1 		$791K Buy
47,028
+7,310
+18% +$127K ﹤0.01% 1938
2018
Q4 		$602K Buy
39,718
+95
+0.2% +$1.63K ﹤0.01% 2007
2018
Q3 		$796K Sell
39,623
-481
-1% -$10.2K ﹤0.01% 1959
2018
Q2 		$782K Buy
40,104
+58
+0.1% +$917 ﹤0.01% 1944
2018
Q1 		$547K Buy
40,046
+103
+0.3% +$1.36K ﹤0.01% 2053
2017
Q4 		$542K Buy
39,943
+9,300
+30% +$134K ﹤0.01% 2061
2017
Q3 		$482K Hold
30,643
– – ﹤0.01% 2108
2017
Q2 		$527K Sell
30,643
-8,000
-21% -$122K ﹤0.01% 2046
2017
Q1 		$589K Hold
38,643
– – ﹤0.01% 1998
2016
Q4 		$508K Hold
38,643
– – ﹤0.01% 2034
2016
Q3 		$437K Buy
38,643
+43
+0.1% +$516 ﹤0.01% 2067
2016
Q2 		$460K Buy
38,600
+5,500
+17% +$74K ﹤0.01% 1996
2016
Q1 		$504K Hold
33,100
– – ﹤0.01% 1968
2015
Q4 		$534K Buy
33,100
+13,700
+71% +$200K ﹤0.01% 1929
2015
Q3 		$242K Hold
19,400
– – ﹤0.01% 2225
2015
Q2 		$321K Hold
19,400
– – ﹤0.01% 2175
2015
Q1 		$310K Hold
19,400
– – ﹤0.01% 2176
2014
Q4 		$302K Hold
19,400
– – ﹤0.01% 2173
2014
Q3 		$267K Hold
19,400
– – ﹤0.01% 2198
2014
Q2 		$311K Hold
19,400
– – ﹤0.01% 2164
2014
Q1 		$327K Hold
19,400
– – ﹤0.01% 2118
2013
Q4 		$409K Hold
19,400
– – ﹤0.01% 2000
2013
Q3 		$422K Sell
19,400
-1,400
-7% -$29.9K ﹤0.01% 1958
2013
Q2 		$389K Buy
+20,800
New +$379K ﹤0.01% 1966

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

T. Rowe Price Associates's NXGN Position: Q4 2023 in Review

T. Rowe Price Associates sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 53,217 shares — an estimated $1.26M sold.

T. Rowe Price Associates first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $1.28M in Q4 2020. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • T. Rowe Price Associates reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 53,217 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $1.26M.
  • T. Rowe Price Associates first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • T. Rowe Price Associates's NextGen Healthcare, Inc. Common Stock position peaked at $1.28M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.